Our formulations are developed with a pharmaceutical mindset prioritising purity, traceability, and delivery performance. From raw material sourcing to encapsulation and third-party testing, every step is designed to ensure consistency, safety, and scientific integrity.
“China as a supply route” is not the issue but standards are.
Here’s how premium, audited supply differs from low-trust commodity NAD+.
Chair time (often ≳60 minutes) caps throughput and forces linear overhead growth.
The experience can be immediate and intense, with some patients feeling overwhelmed, giddy, nauseous, or dizzy following the sudden surge. This rapid spike is often followed by a sharp decline, creating a “crash” effect that may prompt the use of adjunctive oral NAD⁺ products as rescue support in an attempt to stabilise the effects.
Designed as a “take-home IV equivalent” enabling fast dispensing in ~5 minutes.
LNP-NAD⁺ Supports high-retention, recurring revenue programmes driven by consistency.
LNP encapsulation protects NAD+ and supports more consistent delivery, while strict sourcing and independent testing ensure every batch meets high quality standards.
